These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26141511)

  • 1. An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.
    Gueorguieva R; Wu R; Tsai WM; O'Connor PG; Fucito L; Zhang H; O'Malley SS
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1586-99. PubMed ID: 26141511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of abstinence from heavy drinking during treatment in COMBINE and external validation in PREDICT.
    Gueorguieva R; Wu R; O'Connor PG; Weisner C; Fucito LM; Hoffmann S; Mann K; O'Malley SS
    Alcohol Clin Exp Res; 2014 Oct; 38(10):2647-2656. PubMed ID: 25346505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acamprosate in the treatment of alcohol dependence.
    Mason BJ
    Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
    Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
    Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
    J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
    Kranzler HR; Gage A
    Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.
    Chick J; Howlett H; Morgan MY; Ritson B
    Alcohol Alcohol; 2000; 35(2):176-87. PubMed ID: 10787394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.
    Mason BJ; Lehert P
    Alcohol Clin Exp Res; 2012 Mar; 36(3):497-508. PubMed ID: 21895717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
    Soyka M; Preuss U; Schuetz C
    Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    Mason BJ
    J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study.
    Pelc I; Verbanck P; Le Bon O; Gavrilovic M; Lion K; Lehert P
    Br J Psychiatry; 1997 Jul; 171():73-7. PubMed ID: 9328500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients.
    Baltieri DA; de Andrade AG
    Braz J Psychiatry; 2003 Sep; 25(3):156-9. PubMed ID: 12975689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol Use Disorder Treatment: The Association of Pretreatment Use and the Role of Drinking Goal.
    Berger L; Brondino M; Fisher M; Gwyther R; Garbutt JC
    J Am Board Fam Med; 2016; 29(1):37-49. PubMed ID: 26769876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
    Gual A; Lehert P
    Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.